Samsung Biologics
KOSE:A207940
1.877.331,38
₩0,00 (0,00%)
1.877.331,38
₩0,00 (0,00%)
End-of-day quote: 11/11/2025

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

This stock is no longer listed on the stock exchange.

₩33,55k
Earnings Per Share
₩98,44k
Revenue Per Share
55,23%
Gross Margin %
₩86.903,45 B
Market Cap
₩919,00 B
Long-Term Debt
Earnings Per Share
₩33,55k
Revenue Per Share
₩98,44k
Gross Margin %
55,23%
Market Cap
₩86.903,45 B
Long-Term Debt
₩919,00 B

Financials

Year Year 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share ₩33,55k ₩23,40k ₩18,53k ₩17,58k ₩9,15k ₩5,60k
Earnings Earnings ₩1,55T ₩1,08T ₩857,70B ₩813,64B ₩393,59B ₩240,96B
RPS Revenue Per Share ₩98,44k ₩98,24k ₩79,81k ₩64,84k ₩36,44k ₩27,07k
Revenue Revenue ₩4,56T ₩4,55T ₩3,69T ₩3,00T ₩1,57T ₩1,16T
OCF Operating Cash Flow ₩2,06T ₩1,66T ₩1,67T ₩953,05B ₩454,60B ₩202,09B
FCF Free Cash Flow ₩1,32T ₩355,68B ₩671,16B ₩-3,79B ₩48,34B ₩62,43B
OM Operating Margin 45,42% 29,03% 30,14% 32,77% 34,27% 25,14%
GM % Gross Margin % 55,23% 50,01% 48,57% 48,67% 46,13% 35,51%
FCFS Free Cash Flow Per Share ₩0,00 ₩6,09k ₩12,12k ₩-1.238,41 ₩777,18 ₩1,24k
LT Debt Long-Term Debt ₩919,00B ₩1,01T ₩239,78B ₩965,09B ₩1,11T ₩571,45B
Sha. Stocks 46,29M 46,29M 46,29M 46,29M 43,03M 43,03M
×